Literature DB >> 10758222

Laser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing.

S H Sinclair1, R Alaniz, P Presti.   

Abstract

Grid laser is recognized as an extremely effective treatment of diabetic macular edema, although it causes significant chorioretinal damage when applied and scars that expand with time. The purpose of this study is to compare the effects of two methods of grid laser photocoagulation for diabetic macular edema on high-contrast target discrimination in the central visual field. Grid laser photocoagulation with the Early Treatment Diabetic Retinopathy Study intensity burns has previously been shown to cause full retinal thickness burns. In this study, it produced severe destruction of paraxial vision, most marked at 2 degrees to 10 degrees from fixation. Grid laser using threshold-level burns, in contrast, appeared to produce some improvement in thresholded high-contrast vision at eccentricities from 2 degrees to 3 degrees outward, but failed to normalize visual parameters at these intercepts or at intercepts closer to fixation. Therefore, the recommendations are made (1) to use screening modalities other than biomicroscopic perception of retinal swelling to define earlier opportunities for intervention in the diabetic maculopathic process and (2) to use threshold or sub-threshold methods of laser grid photocoagulation for treating leakage and/or edema.

Entities:  

Mesh:

Year:  1999        PMID: 10758222     DOI: 10.3109/08820539909069540

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  6 in total

1.  Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.

Authors:  J K Luttrull; D C Musch; M A Mainster
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  "Light" versus "classic" laser treatment for clinically significant diabetic macular oedema.

Authors:  F Bandello; A Polito; M Del Borrello; N Zemella; M Isola
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Restoration of retinal structure and function after selective photocoagulation.

Authors:  Alexander Sher; Bryan W Jones; Philip Huie; Yannis M Paulus; Daniel Lavinsky; Loh-Shan S Leung; Hiroyuki Nomoto; Corinne Beier; Robert E Marc; Daniel Palanker
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

4.  Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.

Authors:  Masahiko Shimura; Toru Nakazawa; Kanako Yasuda; Takashi Shiono; Kohji Nishida
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

5.  Monotherapy laser photocoagulation for diabetic macular oedema.

Authors:  Eliane C Jorge; Edson N Jorge; Mayra Botelho; Joyce G Farat; Gianni Virgili; Regina El Dib
Journal:  Cochrane Database Syst Rev       Date:  2018-10-15

6.  Subthreshold Micropulse Photocoagulation for Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion including Best-Corrected Visual Acuity Greater Than 20/40.

Authors:  Keiji Inagaki; Kishiko Ohkoshi; Sachiko Ohde; Gautam A Deshpande; Nobuyuki Ebihara; Akira Murakami
Journal:  J Ophthalmol       Date:  2014-09-04       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.